Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-13.1%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.07 | -34.2% |
| 2024 | 0.10 | -4.1% |
| 2023 | 0.11 | +4.1% |
| 2022 | 0.10 | +396.6% |
| 2021 | 0.02 | +127.8% |
| 2020 | -0.08 | +41.7% |
| 2019 | -0.13 | - |